Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension.

Blacher J, Amah G, Girerd X, Kheder A, Ben Mais H, London GM, Safar ME.

Am J Hypertens. 1997 Dec;10(12 Pt 1):1326-34.

PMID:
9443767
2.

Influence of the arterial blood pressure and nonhemodynamic factors on regional arterial wall properties in moderate essential hypertension.

Duprez DA, De Buyzere ML, Verloove HH, Kaufman JM, Van Hoecke MJ, Clement DL.

J Hum Hypertens. 1996 Apr;10(4):251-6.

PMID:
8736457
3.
4.

Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients.

Girerd X, Giannattasio C, Moulin C, Safar M, Mancia G, Laurent S.

J Am Coll Cardiol. 1998 Apr;31(5):1064-73.

5.
6.

Differential responses of the heart and vasculature to chronic blood pressure reduction in essential hypertension.

Lafleche A, Gautier S, Topouchian J, Wilmet CS, Girerd X, Safar ME, Benetos A.

Clin Pharmacol Ther. 1998 Jul;64(1):96-105.

PMID:
9695724
7.

Post-synaptic alpha-blockade and brachial artery compliance in essential hypertension.

Levenson J, Simon AC, Bouthier JD, Benetos A, Safar ME.

J Hypertens. 1984 Feb;2(1):37-41.

PMID:
6530536
8.

Intrinsic modifications of the brachial and radial arteries in hypertensive humans.

Boutouyrie P, Lacolley P, Laurent S, London GM, Safar ME.

Clin Invest Med. 1994 Apr;17(2):97-106.

PMID:
8004855
9.

Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension.

Schlaich MP, Klingbeil AU, Jacobi J, Delles C, Schneider MP, Schmidt BM, Schmieder RE.

J Hypertens. 2002 Jan;20(1):117-24.

PMID:
11791034
10.

[Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].

Cortés P, Fardella C, Oestreicher E, Gac H, Mosso L, Soto J, Foradori A, Claverie X, Ahuad J, Montero J.

Rev Med Chil. 2000 Sep;128(9):955-61. Spanish.

PMID:
11349499
12.
13.

Assessment of the acute arterial effects of converting enzyme inhibition in essential hypertension: a double-blind, comparative and crossover study.

Topouchian J, Brisac AM, Pannier B, Vicaut E, Safar M, Asmar R.

J Hum Hypertens. 1998 Mar;12(3):181-7.

PMID:
9579768
14.

Arterial compliance abnormalities in isolated systolic hypertension.

Beltran A, McVeigh G, Morgan D, Glasser SP, Neutel JM, Weber M, Finkelstein SM, Cohn JN.

Am J Hypertens. 2001 Oct;14(10):1007-11.

PMID:
11710778
15.

Arterial distensibility and compliance in hypertension.

Reneman RS, Hoeks AP.

Neth J Med. 1995 Oct;47(4):152-61. Review.

PMID:
8538818
16.

T235 variant of the angiotensinogen gene and blood pressure in the Chilean population.

Fardella CE, Claverie X, Vignolo P, Montero J, Villarroel L.

J Hypertens. 1998 Jun;16(6):829-33.

PMID:
9663923
17.

[Arterial compliance during exertion in hypertensive and normal subjects of the same age].

Siché JP, Mansour P, de Gaudemaris R, Mallion JM.

Arch Mal Coeur Vaiss. 1989 Jul;82(7):1077-82. French.

PMID:
2510634
18.

Arterial stiffness in hypertensive subjects with or without end-stage renal disease.

Safar ME, London GM.

Kidney Blood Press Res. 1997;20(2):82-9. Review.

PMID:
9293423
19.

Aldosterone and magnesium in essential arterial hypertension.

Garcia Zozaya JL, Padilla Viloria M, Castro A.

Clin Physiol Biochem. 1988;6(6):293-300.

PMID:
3208481
20.

Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients.

Colussi G, Catena C, Lapenna R, Nadalini E, Chiuch A, Sechi LA.

Diabetes Care. 2007 Sep;30(9):2349-54.

PMID:
17575088
Items per page

Supplemental Content

Support Center